Sunway Healthcare Holdings is preparing for one of Malaysia’s largest listings in recent years, with analysts pointing to hospital expansion, medical tourism, and demographic trends as key growth drivers.
Sunway Healthcare Holdings Bhd, one of Malaysia’s largest private healthcare providers, is preparing for its debut on the Main Market of Bursa Malaysia in what is expected to be one of the country’s biggest initial public offerings (IPOs) in nearly a decade.
The healthcare arm of Sunway Bhd is scheduled to list on March 18, 2026, with shares priced at RM1.45 each. At that price, the IPO is expected to raise up to RM2.86 billion, placing it among the largest Malaysian listings in recent years and highlighting growing investor interest in the healthcare sector.
Sunway Healthcare operates a network of tertiary and quaternary hospitals, complemented by specialised outpatient and ambulatory care centres. In addition to core hospital services, the group provides a range of supporting healthcare offerings including home healthcare, traditional and complementary medicine, and senior living solutions.
Hospital operations currently account for roughly 98 percent of the group’s revenue, reflecting the central role of its medical facilities in the broader healthcare ecosystem developed by the Sunway Group.
The company has built a strong presence within Malaysia’s private healthcare market and has increasingly positioned itself as a regional healthcare provider capable of attracting international patients, particularly from neighbouring Southeast Asian markets.
DETAILS OF THE IPO AND PRICE STABILISATION PLAN
As part of preparations for the listing, Sunway Healthcare has activated a price stabilisation mechanism designed to support orderly trading in the early days following the IPO.
Maybank Investment Bank has been appointed as the stabilising manager for the offering. Under the arrangement, the bank may purchase shares on the open market if the share price comes under pressure shortly after listing.
The stabilisation plan includes an over-allotment option of up to 295,349,400 shares, representing approximately 15 percent of the total shares offered in the IPO. This so-called “green shoe” option allows the stabilising manager to buy back shares during a stabilisation period lasting up to 30 days after the listing date, or until the allotted shares are fully purchased.
Such mechanisms are commonly used in major IPOs to reduce short-term price volatility and help maintain investor confidence during the initial trading period.
The listing marks a significant milestone for Sunway Healthcare as it seeks to expand its hospital network and strengthen its position within Malaysia’s growing private healthcare industry.
EXPANSION PLANS AND GROWTH DRIVERS
Analysts broadly expect Sunway Healthcare to deliver steady growth in the coming years, supported by ongoing hospital expansions and strong demand for healthcare services.
Research firm Malacca Securities projects the group to achieve a three-year compound annual growth rate (CAGR) of 12.6 percent in earnings, with core profit after tax and minority interest forecast to range between RM235.4 million and RM368.1 million over the period.
Much of this growth is expected to come from “brownfield” expansions at existing hospitals, where additional facilities and wards can be added to increase capacity and patient throughput without building entirely new hospitals.
Across its network, Sunway Healthcare plans to expand its licensed bed capacity significantly over the coming decade. Analysts estimate the group’s total capacity could grow by about 74 percent to 3,444 beds by 2032, with the potential to exceed 3,900 beds if additional projects are completed.
These expansions are expected to increase patient volumes and support higher utilisation rates as facilities reach operational maturity.
One area of particular focus is medical tourism. Malaysia has long positioned itself as a regional destination for high-quality yet relatively affordable healthcare services, attracting patients from across Asia, the Middle East, and other regions.
Public Investment Bank noted that Sunway Healthcare is well positioned to benefit from this trend, particularly because of the group’s proximity to Sunway’s integrated hospitality and transport infrastructure. These linkages can make it easier for international patients to combine treatment with accommodation and recovery arrangements.
Malaysia’s ageing population is also expected to support demand for healthcare services over the longer term, as older demographics typically require more frequent medical care and specialised treatment.
VALUATIONS AND ANALYST VIEWS
Ahead of the IPO, analysts have offered generally positive assessments of the company’s growth prospects, though some note that the pricing leaves limited short-term upside.
Public Investment Bank has valued the shares in the range of RM1.35 to RM1.55 based on projected enterprise value-to-EBITDA multiples of 20 to 23 times for the financial year ending 2027. This places Sunway Healthcare at a premium compared with some listed healthcare peers, which typically trade between 14 and 19 times.
The research house said the premium valuation reflects the group’s strong growth outlook, market leadership, and aggressive hospital expansion plans.
TA Securities offered a more bullish assessment, valuing the shares at around RM1.62, roughly 24 percent above comparable sector valuations. The research firm cited the company’s brand strength, operational scale, and rapid hospital ramp-up timelines as factors supporting a higher valuation.
Unlike many healthcare operators where new facilities can take several years to reach profitability, Sunway Healthcare’s hospitals are expected to achieve positive EBITDA within 12 to 18 months of opening, significantly faster than the typical industry timeline of three to five years.
Revenue growth is also expected to remain strong. Analysts estimate that the group could record revenue growth of around 14.7 percent annually between the 2025 and 2027 financial years, driven by expanding bed capacity and improving occupancy rates.
RISKS AND INDUSTRY CHALLENGES
Despite the positive overall outlook, analysts have also identified several risks that could affect the company’s performance.
Potential delays in hospital expansion projects could slow the planned increase in bed capacity. The healthcare sector also faces ongoing workforce challenges, particularly in recruiting and retaining skilled medical professionals.
Another possible headwind is the future implementation of a diagnosis-related group (DRG) payment system in Malaysia’s healthcare sector. Such systems standardise treatment payments and could limit pricing flexibility for private healthcare providers.
Even with these uncertainties, it certainly seems that Sunway Healthcare’s IPO reflects the broader strength of Malaysia’s private healthcare industry, which continues to benefit from rising healthcare demand, regional medical tourism, and expanding healthcare infrastructure.
If successful, the listing could further cement the Sunway group’s position as one of Southeast Asia’s fastest-growing hospital operators.
Sources: The Edge, Business Today, Bloomberg, company filings, analyst research notes. Information provided here is intended for informational use only and should not be construed as investment advice.
